|
|
|
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ / v.20, no.3, 2007³â, pp.221-225
|
( Antinocicepetive Effects of 3,4-Dicaffeoyl Quinic Acid of Ligularia fischeri var. spiciformis ) |
| ;; ;;
|
|
|
 |
|
| |
| ÃÊ ·Ï |
|
|
| The plant Ligularia fischeri var. spiciformis (Compositae) is a candidate for available functional foods. It has been used to treat diabetes mellitus and rheumatoid arthritis. We have reported the isolation of a new eremophilanolide named 6-oxoeremophilenolide and cytotoxic intermedeol together with the isolation of hydrophilic constituents, chlorogenic acid, 3,4-di-O-caffeoylquinic acie (3), and 5-O-[1-butyl]-3,4-di-O-caffeoylquinic acid. Compound 3 was again isolated by combination of silica gel- and ODS column chromatography for the anti-nociceptive action. Compound 3 and 4 were assayed in hot plate- and writhing tests in the rat. Although the three derivatives of caffeic acid exhibited significant anti-nociceptive effects at 10 mg/kg dose (i.p.),(activity potency: 4>3). These results suggest that compound 3 is responsible for at least rheumatoid arthritis, and caffeic acid moiety is the active moiety of dicaffeoylquinic acid. |
| |
| Ű¿öµå |
| Ligularia fischeri var spiciformis;Compositae;3,4-dicaffeoylquinic acid;Caffeic acid methyl ester;Anti-nociceptive; |
| |
|
|
 |
|
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸÁö / v.20, no.3, 2007³â, pp.221-225
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ
ISSN : 1226-3591
UCI : G100:I100-KOI(KISTI1.1003/JNL.JAKO200724737573405)
¾ð¾î : ¿µ¾î |
|
| ³í¹® Á¦°ø : KISTI Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø |
|
|
|
|
|
|